AI Reads Heart Rhythms Brilliantly in the Lab, but a Sweeping Review Finds the Clinic Is Still Waiting

Artificial intelligence has learned to read the electrocardiogram with astonishing skill. Trained on thousands of heart tracings, deep neural networks can now flag arrhythmias, detect silent heart attacks, and even predict heart failure months before symptoms appear, sometimes matching or exceeding the performance of experienced cardiologists. Yet a new systematic review of the field suggests that the journey from impressive laboratory benchmark to trustworthy bedside tool remains far longer than the headline results imply. The study, published in Discover Artificial Intelligence, dissects 83 high-quality studies published between January 2020 and November 2025 and finds a research enterprise that is technically vibrant but methodologically fragile, with deep problems in data diversity, validation, and transparency that could determine whether AI-enhanced cardiology fulfills its promise or stalls at the proof-of-concept stage.

The review, led by Thanuja M and Soumyashree M. Panchal of the Manipal Institute of Technology Bengaluru together with Prasanna Lakshmi G S of Sai Vidya Institute of Technology, followed the PRISMA 2020 guidelines that govern rigorous evidence synthesis. The team searched PubMed, IEEE Xplore, Scopus, Web of Science, and other major databases, screening 1,247 records before settling on the 83 studies that met their inclusion criteria. Each study was then scored with a customized quality-assessment tool covering data sources, preprocessing clarity, model development rigor, evaluation practices, external validation, reproducibility, and interpretability. The verdict was sobering: only 32 studies, or 38.6 percent, showed a low risk of bias. Another 49.4 percent carried moderate risk, and 12 percent were judged high risk. In other words, nearly two-thirds of the published evidence base for AI-based ECG diagnosis rests on studies with methodological weaknesses that could inflate or distort their reported performance.

The electrocardiogram itself is a deceptively simple signal. Electrodes on the skin capture the heart’s electrical activity, producing the familiar P wave, QRS complex, and T wave that correspond to atrial depolarization, ventricular depolarization, and ventricular repolarization. Clinicians read these waveforms for subtle clues: a slightly elevated ST segment may signal an evolving myocardial infarction, an irregularly irregular rhythm points to atrial fibrillation, and a prolonged QT interval suggests vulnerability to dangerous arrhythmias. These are pattern-recognition tasks that demand years of training and remain subject to variability between observers. Automating them has been a dream almost as old as the ECG itself, but early rule-based systems, which measured predefined features and compared them against fixed criteria, plateaued well below expert human performance because they could not capture the holistic, nuanced pattern recognition that experienced interpreters develop.

Machine learning changed the equation by learning features directly from data rather than relying on hand-crafted measurements. The review found that traditional machine learning methods, used in 49.4 percent of the studies surveyed, still hold real advantages in specific settings. Ensemble classifiers such as Random Forest and Gradient Boosting consistently outperform single classifiers by 4 to 7 percent in accuracy, and expert-derived features grounded in clinical knowledge of ECG morphology add another 5 to 10 percent compared with generic statistical features. Traditional approaches also demand far less training data, making them the sensible choice when fewer than 1,000 recordings are available, and they offer inherent interpretability through feature importance scores and coefficient magnitudes. But on raw or minimally preprocessed signals, they trail deep learning by 8 to 15 percent, a gap that explains why neural networks have come to dominate the field, appearing in 78 percent of studies from 2023 to 2025.

Among deep architectures, convolutional neural networks reign supreme, employed in 67 percent of the reviewed studies. CNNs apply learnable filters across the one-dimensional ECG signal, automatically detecting local morphological patterns such as QRS complexes and ST-segment changes, with pooling layers providing translation invariance so that clinically relevant features are recognized regardless of their exact timing. Their weakness is temporal: they struggle to capture dependencies spanning multiple heartbeats. That role falls to Long Short-Term Memory networks, a form of recurrent architecture whose internal memory gates preserve information across hundreds of time steps, making them well suited to rhythm analysis and to catching paroxysmal atrial fibrillation hidden in long recordings. Hybrid CNN-LSTM models, which pair convolutional feature extraction with temporal modeling, appeared in 34 percent of recent studies and consistently outperform standalone architectures by 3 to 8 percent on benchmarks, particularly for conditions involving both morphological abnormalities and rhythm disturbances. Emerging tools, including transformer self-attention models in 15 percent of 2024 and 2025 studies and graph neural networks that model relationships between ECG leads, are pushing the frontier further, while transfer learning from large repositories such as PTB-XL, which contains 21,799 recordings, cuts training data requirements by 60 to 80 percent.

Before any model sees data, however, the signal must be cleaned, and the review devotes detailed attention to this unglamorous but critical stage. Raw ECG recordings are contaminated by baseline wander, powerline interference at 50 or 60 hertz, muscle activity, respiratory artifacts, and motion noise from patient movement or electrode displacement. Traditional frequency-selective filters, including bandpass filters with cutoffs between 0.5 and 150 hertz and Butterworth designs prized for their maximally flat response, remain workhorses, but newer techniques are gaining ground. Wavelet transforms decompose the signal in time and frequency simultaneously, isolating noise while preserving transient diagnostic features. Empirical mode decomposition adaptively breaks the signal into intrinsic components for selective noise removal. Adaptive filters such as Least Mean Squares algorithms adjust their parameters dynamically, and Kalman filters support real-time estimation. Most strikingly, neural networks themselves, including denoising autoencoders and generative adversarial networks, now learn noise patterns directly from data. Segmentation, normalization, and R-peak alignment complete the pipeline, and the review notes that even deep learning models, which supposedly bypass manual feature engineering, remain heavily dependent on high-quality preprocessing.

The most alarming findings concern the data itself. Ninety-five percent of the reviewed studies relied on publicly available ECG repositories, with only 3 percent using private institutional data and 2 percent collecting their own recordings. That reliance on open datasets aids reproducibility but concentrates risk: 78 percent of public ECG data originates from North America or Europe, ethnicity is reported in fewer than 10 percent of datasets, pediatric populations account for less than 3 percent of recordings, and average female representation stands at 41.5 percent. Annotation quality is equally uneven, with only 35 percent of datasets specifying annotator qualifications and just 22 percent reporting inter-annotator agreement. The consequences are measurable. Studies performing cross-dataset validation report average performance degradation of 8 to 15 percent when models are tested on data from different sources, and only 28 percent of studies include any form of external validation. A model trained primarily on middle-aged European patients may simply fail when deployed in a demographically different hospital, a phenomenon known as dataset shift that raises serious fairness and equity concerns.

Transparency poses another barrier. Deep networks function as black boxes, producing accurate predictions with little insight into their reasoning, and clinicians justifiably hesitate to act on alerts they cannot interrogate. Explainable AI methods aim to open that box: SHAP values, rooted in game theory, quantify each feature’s marginal contribution to a prediction, while LIME approximates a complex model locally with an interpretable surrogate. Visual techniques such as Class Activation Maps and saliency maps highlight which portions of the waveform drove a classification, letting observers see exactly which ECG segments influenced the model’s decision. Yet only 52 percent of recent studies incorporate any explainability method, demographic fairness assessments remain rare, and the review argues that current explanations often satisfy technical curiosity without answering the questions clinicians actually ask, such as whether a model’s reasoning aligns with established pathophysiology and whether its recommendation can be trusted for a specific patient.

The reproducibility picture is equally troubling. Only 29 percent of reviewed studies made their code publicly available, preprocessing details were frequently too sparse to permit replication, and the field lacks standardized benchmarks, making cross-study comparison nearly impossible. Few papers include comprehensive ablation analyses quantifying which preprocessing steps or architectural components actually drive performance. Evaluation practices compound the problem: most studies emphasize overall accuracy while neglecting class-specific performance, calibration, and uncertainty quantification, all of which matter enormously in clinical decision-making where a false negative on a lethal arrhythmia carries very different stakes than a false alarm.

The authors close with a roadmap that reads as both a critique and a call to action. In the near term, they urge standardized evaluation benchmarks, mandatory demographic reporting, and routine external validation; in the medium term, multi-center data consortia and explainability integrated with clinical workflows; and in the long term, prospective validation in diverse practice settings and continuous learning systems that adapt as populations change. They also point to federated learning, which trains models across institutions without centralizing sensitive patient data, as a promising route around privacy barriers. The convergence of abundant ECG data, powerful architectures, and pressing clinical need creates a genuine opportunity, the review concludes, but seizing it will require engineers to work alongside clinicians from project inception, researchers to prize generalizability over benchmark scores, and the whole community to treat transparency and fairness not as optional extras but as the foundation of AI-assisted cardiovascular care.

Subject of Research: Artificial intelligence methods for ECG-based cardiovascular disease prediction

Article Title: A systematic survey of artificial intelligence methods for ECG-based cardiovascular disease prediction

Article References: A systematic survey of artificial intelligence methods for ECG-based cardiovascular disease prediction. (n.d.). https://doi.org/10.1007/s44163-026-02170-7

Image Credits: AI Generated

DOI: 10.1007/s44163-026-02170-7

Keywords: artificial intelligence, electrocardiogram, cardiovascular disease, deep learning, machine learning, explainable AI, systematic review, clinical validation, dataset bias, CNN, LSTM, signal preprocessing